A small clinical trial suggests a vitamin D analog may dismantle pancreatic cancer's protective shield, making tumors more susceptible to chemotherapy and immune attack, particularly in patients with high levels of the vitamin D receptor.
Vitamin D Analog Shows Promise in Breaking Pancreatic Cancer's Defenses
A small clinical trial suggests a vitamin D analog may dismantle pancreatic cancer's protective shield, making tumors more susceptible to chemotherapy and immune attack, particularly in patients with high levels of the vitamin D receptor.
Pancreatic cancer · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.